- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 19 Reference Ions Near m/z 825.5728
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000007581 Reliable | 825.5726 | 825.5723 ~ 825.5729 MzDiff: 2.6 ppm |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
4.32 (100%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000007354 Unreliable | 825.5787 | 825.5782 ~ 825.5789 MzDiff: 2.6 ppm |
Not Annotated | 5.33 (0%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000009091 Unreliable | 825.5825 | 825.5825 ~ 825.5825 MzDiff: none |
Not Annotated | 3.09 (0%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000009099 Unreliable | 825.5646 | 825.5646 ~ 825.5646 MzDiff: none |
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (BioDeep_00000031684) Formula: C46H81O10P (824.5567) |
3.08 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000009106 Unreliable | 825.5735 | 825.5735 ~ 825.5735 MzDiff: none |
SM(d20:1/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (BioDeep_00000215742) Formula: C45H81N2O9P (824.5679) |
3.08 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000021294 Unreliable | 825.5743 | 825.5743 ~ 825.5743 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
1.26 (100%) | Mus musculus [UBERON:0001499] muscle of arm |
MSI_000000790 Unavailable | 825.5825 | 825.5825 ~ 825.5825 MzDiff: none |
Not Annotated | -0.6 (0%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000000808 Unavailable | 825.5646 | 825.5646 ~ 825.5646 MzDiff: none |
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (BioDeep_00000031684) Formula: C46H81O10P (824.5567) |
-0.61 (100%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000000812 Unavailable | 825.5735 | 825.5735 ~ 825.5735 MzDiff: none |
SM(d20:1/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (BioDeep_00000215742) Formula: C45H81N2O9P (824.5679) |
-0.61 (100%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000004125 Unreliable | 825.5806 | 825.5806 ~ 825.5806 MzDiff: none |
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000186162) Formula: C45H78NO9P (807.5414) |
1 (100%) | Homo sapiens [UBERON:0002107] liver |
MSI_000028803 Unreliable | 825.5652 | 825.5652 ~ 825.5652 MzDiff: none |
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (BioDeep_00000031684) Formula: C46H81O10P (824.5567) |
0.33 (100%) | Macropus giganteus [UBERON:0001891] midbrain |
MSI_000029129 Unreliable | 825.5759 | 825.5759 ~ 825.5759 MzDiff: none |
PC(18:0/20:3(5Z,8Z,11Z)-O(14R,15S)) (BioDeep_00000211199) Formula: C46H84NO9P (825.5883) |
1.92 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000029318 Unreliable | 825.5652 | 825.5652 ~ 825.5652 MzDiff: none |
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (BioDeep_00000031684) Formula: C46H81O10P (824.5567) |
1.29 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000030238 Unreliable | 825.5709 | 825.5709 ~ 825.5709 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
2.06 (100%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000030944 Unreliable | 825.5759 | 825.5759 ~ 825.5759 MzDiff: none |
PC(18:0/20:3(5Z,8Z,11Z)-O(14R,15S)) (BioDeep_00000211199) Formula: C46H84NO9P (825.5883) |
0.51 (100%) | Macropus giganteus [UBERON:0003027] cingulate cortex |
MSI_000031604 Unreliable | 825.5709 | 825.5709 ~ 825.5709 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
0.2 (100%) | Macropus giganteus [UBERON:0006093] precuneus cortex |
MSI_000061524 Unavailable | 825.5756 | 825.5756 ~ 825.5756 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
-0.34 (100%) | Mus musculus [UBERON:0000956] cerebral cortex |
MSI_000062478 Unavailable | 825.5756 | 825.5756 ~ 825.5756 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
-0.38 (100%) | Mus musculus [UBERON:0001950] neocortex |
MSI_000062877 Unavailable | 825.5756 | 825.5756 ~ 825.5756 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
-0.4 (100%) | Mus musculus [UBERON:0002421] hippocampal formation |
Found 22 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
SM(d20:1/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) Formula: C45H81N2O9P (824.5679) Adducts: [M+H]+ (Ppm: 2.1) |
Mus musculus (Urinary bladder) |
HR2MSI_mouse_urinary_bladder - S096Resolution: 10μm, 260x134
Mass spectrometry imaging of phospholipids in mouse urinary bladder (imzML dataset) |
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_17Resolution: 17μm, 208x108
1 male adult wild-type rat was obtained from Inserm U1085 - Irset Research Institute (University of Rennes1, France). Animals were age 60 days and were reared under ad-lib conditions. Care and handling of all animals complied with EU directive 2010/63/EU on the protection of animals used for scientific purposes. The whole epididymis was excised from each animal immediately post-mortem, loosely wrapped rapidly in an aluminum foil and a 2.5% (w/v) carboxymethylcellulose (CMC) solution was poured to embed the epididymis to preserve their morphology. To remove air bubbles, the filled aluminum molds was gently freezed by depositing it on isopentane or dry ice, then on the nitrogen vapors and finally by progressively dipping the CMC/sample coated with aluminum foil into liquid nitrogen (or only flush with liquid nitrogen). Frozen tissues were stored at -80 °C until use to avoid degradation. |
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_18Resolution: 17μm, 208x104
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 16.9) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_43Resolution: 17μm, 298x106
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.1) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_44Resolution: 17μm, 299x111
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.6) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_46Resolution: 17μm, 298x106
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.4) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_47Resolution: 17μm, 301x111
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.5) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_48Resolution: 17μm, 294x107
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.4) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_04Resolution: 17μm, 178x91
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.5) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_03Resolution: 17μm, 159x110
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.5) |
Rattus norvegicus (normal) |
epik_dhb_head_ito01_05Resolution: 17μm, 183x105
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17.1) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_06Resolution: 17μm, 183x103
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 17) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_14Resolution: 17μm, 205x103
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 15.2) |
Mus musculus (Left upper arm) |
357_l_total ion countResolution: 50μm, 97x131
Diseased |
|
PE(20:0/PGJ2) Formula: C45H80NO10P (825.552) Adducts: [M-H2O+NH4]+ (Ppm: 10.3) |
Mus musculus (Lung) |
image4Resolution: 40μm, 162x156
Fig 6c
Fig. 6 MALDI-MSI of U13C-PC16:0/16:0 acyl chain remodeling. A: Averaged MALDI mass spectrum from lung tissue collected from mice euthanized 12 h after administration of D9-choline and U13C-DPPC–containing Poractant alfa surfactant. The ion at m/z 828.6321 is assigned as the [M+Na]+ ion of 13C24-PC16:0_20:4 formed by acyl remodeling of U13C-PC16:0/16:0. The “NL” value refers to the intensity of the base peak in the full range MS1 spectrum. B: MS/MS spectrum of precursor ions at m/z 828.5 ± 0.5 with fragment ions originating from [13C24-PC16:0_20:4+Na]+ annotated. Part-per-million (ppm) mass errors are provided in parentheses. C, D: MALDI-MSI data of [U13C-DPPC+Na]+ (blue), [PC36:4+Na]+ (green) and [13C24-PC16:0_20:4+Na]+ (red) in lung tissue collected from mice (C) 12 h and (D) 18 h after label administration. All images were visualized using total-ion-current normalization and hotspot removal (high quantile = 99%). MS/MS, tandem mass spectrometry; MSI, mass spectrometry imaging; PC, phosphatidylcholine; U13C-DPPC, universally 13C-labeled dipalmitoyl PC. |
|
PE(20:0/PGJ2) Formula: C45H80NO10P (825.552) Adducts: [M-H2O+NH4]+ (Ppm: 9.1) |
Mus musculus (Lung) |
image2Resolution: 40μm, 550x256
Supplementary Figure S6. Ion distribution images for (a) [PC36:4+Na]+ (m/z 804.5514) and (b)
[PC38:6+Na]+ (m/z 828.5515) obtained from mouse lung tissue collected 6 h after administration of D9-
choline and U13C-DPPC–containing CHF5633. Parts-per-million (ppm) mass errors are indicated in
parentheses. (c) Magnification of the boxed region in (a) with selected bronchiolar regions outlined in
white boxes. (d) The corresponding H&E-stained tissue section with the same selected bronchiolar
regions outlined in black boxes. These data demonstrate the co-localisation of the polyunsaturated lipids
PC36:4 and PC38:6 with the bronchiolar regions of the lung. All MSI images were visualised using
total ion current normalisation and hotspot removal (high quantile = 99%). |
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+NH4]+ (Ppm: 19.3) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
PC(18:0/20:3(5Z,8Z,11Z)-O(14R,15S)) Formula: C46H84NO9P (825.5883) Adducts: [M]+ (Ppm: 14.4) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) Formula: C46H81O10P (824.5567) Adducts: [M+H]+ (Ppm: 4.7) |
Homo sapiens (esophagus) |
LNTO22_1_3Resolution: 75μm, 121x68
|
|
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) Formula: C46H81O10P (824.5567) Adducts: [M+H]+ (Ppm: 5.4) |
Homo sapiens (esophagus) |
LNTO22_2_2Resolution: 75μm, 135x94
|
|
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) Formula: C46H81O10P (824.5567) Adducts: [M+H]+ (Ppm: 15) |
Homo sapiens (colorectal adenocarcinoma) |
240TopL, 210TopR, 230BottomL, 220BottomR-centroidResolution: 50μm, 142x141
|
|
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) Formula: C46H81O10P (824.5567) Adducts: [M+H]+ (Ppm: 14.3) |
Drosophila melanogaster (brain) |
Drosophila18Resolution: 5μm, 686x685
Sample information
Organism: Drosophila melanogaster
Organism part: Brain
Condition: Healthy
Sample preparation
Sample stabilisation: Frozen
Tissue modification: Frozen
MALDI matrix: 2,5-dihydroxybenzoic acid (DHB)
MALDI matrix application: TM sprayer
Solvent: Aceton/water
MS analysis
Polarity: Positive
Ionisation source: Prototype
Analyzer: Orbitrap
Pixel size: 5μm × 5μm
Annotation settings
m/z tolerance (ppm): 3
Analysis version: Original MSM
Pixel count: 469910
Imzml file size: 696.23 MB
Ibd file size: 814.11 MB |
|